Abstract:Isolation of tissue-specific fetal stem cells and derivation of primary organoids is limited to samples obtained from termination of pregnancies, hampering prenatal investigation of fetal development and congenital diseases. Therefore, new patient-specific in vitro models are needed. To this aim, isolation and expansion of fetal stem cells during pregnancy, without the need for tissue samples or reprogramming, would be advantageous. Amniotic fluid (AF) is a source of cells from multiple developing organs. Using single-cell analysis, we characterized the cellular identities present in human AF. We identified and isolated viable epithelial stem/progenitor cells of fetal gastrointestinal, renal and pulmonary origin. Upon culture, these cells formed clonal epithelial organoids, manifesting small intestine, kidney tubule and lung identity. AF organoids exhibit transcriptomic, protein expression and functional features of their tissue of origin. With relevance for prenatal disease modeling, we derived lung organoids from AF and tracheal fluid cells of congenital diaphragmatic hernia fetuses, recapitulating some features of the disease. AF organoids are derived in a timeline compatible with prenatal intervention, potentially allowing investigation of therapeutic tools and regenerative medicine strategies personalized to the fetus at clinically relevant developmental stages.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to develop a new method to isolate and culture fetal epithelial organoids from amniotic fluid and tracheal fluid for prenatal research on fetal development and congenital diseases. Specifically, the authors aim to: 1. **Overcome the limitations of existing technologies**: Currently, the isolation of tissue - specific fetal stem cells and the generation of primary organoids mainly rely on samples obtained after termination of pregnancy, which limits the prenatal research on fetal development and congenital diseases. Therefore, new patient - specific in vitro models are needed. 2. **Provide a non - invasive cell source**: Through single - cell analysis, identify and isolate live epithelial stem / progenitor cells present in amniotic fluid, which are derived from multiple organs of the fetus (such as the gastrointestinal tract, kidneys, and lungs). These cells can be cultured in vitro to form organoids, thus avoiding the need for fetal tissue samples or reprogramming. 3. **Establish organoid models that match the fetal development stage**: The generated organoids can exhibit the transcriptomic, protein expression, and functional characteristics of their origin tissues, especially at the critical time points of prenatal diagnosis and treatment, allowing the study of personalized medical tools and regenerative medicine strategies for the fetus. 4. **Apply to specific congenital disease models**: For example, the authors derived lung organoids from amniotic fluid and tracheal fluid cells of fetuses with congenital diaphragmatic hernia (CDH), simulating some disease characteristics and providing the possibility for prenatal disease modeling. Through these efforts, this study aims to provide a new tool for prenatal medicine to gain a deeper understanding of the biological mechanisms during fetal development and provide new approaches for the early diagnosis and treatment of congenital diseases. ### Formula Examples When discussing cell proliferation and differentiation, the following formulas may be used to describe experimental results: - **Cell Proliferation Rate**: \[ \text{Proliferation Rate}=\frac{\text{Number of EdU - positive cells}}{\text{Total number of cells}}\times100\% \] - **Gene Expression Level** (represented using Counts Per Million (CPM) normalization): \[ \text{Gene Expression Level}=\frac{\text{Number of gene reads}}{\text{Total number of reads}}\times1,000,000 \] These formulas are helpful for quantitative analysis of experimental data, ensuring the accuracy and reproducibility of the results.

Single-cell guided prenatal derivation of primary fetal epithelial organoids from human amniotic and tracheal fluids

Minimally invasive derivation of primary human epithelial organoids from fetal fluids

Organoid modeling of human fetal lung alveolar development reveals mechanisms of cell fate patterning and neonatal respiratory disease

An integrated transcriptomic cell atlas of human endoderm-derived organoids

Modeling Human Organ Development and Diseases With Fetal Tissue-Derived Organoids

Development and Functional Characterization of Fetal Lung Organoids

A distal lung organoid model to study interstitial lung disease, viral infection and human lung development

Early human fetal lung atlas reveals the temporal dynamics of epithelial cell plasticity

Generating Functional Multicellular Organoids from Human Placenta Villi

Generation of Complete Multi−Cell Type Lung Organoids From Human Embryonic and Patient‐Specific Induced Pluripotent Stem Cells for Infectious Disease Modeling and Therapeutics Validation

A patterned human primitive heart organoid model generated by pluripotent stem cell self-organization

Single-cell assessment of primary and stem cell-derived human trophoblast organoids as placenta-modeling platforms

A 3D system to model human pancreas development and its reference single-cell transcriptome atlas identify signaling pathways required for progenitor expansion

Human organoid systems in modeling reproductive tissue development, function, and disease

Generation of human gastric assembloids from primary fetal organoids

A human fetal lung cell atlas uncovers proximal-distal gradients of differentiation and key regulators of epithelial fates

Establishment of Patient-Derived Organoid Model from Hydrothorax and Ascites

Deciphering Endothelial and Mesenchymal Organ Specification in Vascularized Lung and Intestinal Organoids

Influence of mesenchymal and biophysical components on distal lung organoid differentiation

Long-term expanding human airway organoids for disease modeling

Soluble ECM promotes organotypic formation in lung alveolar model